Alexion Reports Third Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Alexion Pharma (ALXN) Tops Q3 EPS by 66c, Updates FY Guidance
October 29, 2020 6:33 AM EDTAlexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $3.24, $0.66 better than the analyst estimate of $2.58. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Alexion Pharma sees FY2020 EPS of $11.70-$12.00, versus the consensus of... More



